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I. IDENTIFICATION OF CHEMICAL DIABETES 
The Definition of Chemical Diabetes 
By Stefan S. Fajans 
The natural history of diabetes mellitus 
can be arbitrarily divided into four 
stages based on the presence or ab- 
sence of abnormal carbohydrate me- 
tabolism. Overt diabetes is the most 
advanced stage, characterized by ele- 
vated fasting blood glucose concen- 
tration and classical symptoms. This 
stage is divided into ketotic and non- 
ketotic forms. Preceding overt diabe- 
tes is the latent or chemical diabetic 
stage, with no symptoms of diabetes 
but demonstrable abnormality of oral 
or intravenous glucose tolerance. Sub- 
clinical diabetes is an earlier stage 
when glucose tolerance is abnormal 
only with stress, such as pregnancy or 
the administration of cortisone. The 
earliest stage, prediabetes, extends 
from conception until the first demon- 
strable abnormality in glucose toler- 
ance. In groups of presumed predia- 
betic individuals, delayed and/or de- 
creased plasma insulin response to 
glucose has been noted. Progression 
of the diabetes may not occur, may 
occur very slowly or very rapidly, and 
regression to an earlier stage of ab- 
normality may also occur. 
B EFORE PROCEEDING WITH A DEFINITION of chemical diabetes, we need to review the stages in the natural history of the disease in order to 
put the stage of chemical diabetes in proper perspective. Any classification 
of genetic diabetes mellitus must be somewhat arbitrary, as is the classifica- 
tion that we have employed for a number of years.l Table 1 presents a scheme 
depicting the natural history of diabetes as divided into four stages.’ This 
classification is based on the presence or absence of abnormalities of carbo- 
hydrate metabolism. 
Overt or frank diabetes is the most advanced of these stages. Classical 
symptoms of the disease may be present: There is fasting hyperglycemia; 
a glucose tolerance test is not necessary for diagnosis. This stage of the 
disease has been subdivided into the nonketotic and ketotic forms of the 
disease. 
The preceding stage is latent or chemical diabetes. A latent diabetic is an 
individual who has no symptoms referable to the disease but in whom a 
definite diagnosis of diabetes can be established by presently accepted labora- 
tory procedures. The fasting blood glucose level may be elevated but is usually 
normal. However, the oral or intravenous glucose tolerance test is definitely 
abnormal, whatever the criteria for an abnormal glucose tolerance test may be. 
An earlier stage is subclinical diabetes. 2 Here, not only the fasting blood 
sugar level but also the glucose tolerance test is normal under usual circum- 
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stances. However, diabetes may be suspected because of evidence of insuffi- 
cient functional reserve of the islet cells. An example would be a woman who 
has a normal glucose tolerance test but who has a history of abnormality 
of standard glucose tolerance during pregnancy. The latter has been termed 
pregnancy or gestational diabetes. A high proportion of such women develop 
latent or overt diabetes in the years which follow. Another example of sub- 
clinical diabetes may be an individual with a normal standard glucose tolerance 
test but an abnormal cortisone-glucose tolerance test in the nonpregnant state. 
The earliest stage is prediabetes. 2 The prediabetic state exists prior to the 
onset of identifiable diabetes mellitus, whether it be overt, latent, or sub- 
clinical. It identifies the interval of time from conception until the demonstra- 
tion of impaired glucose tolerance in an individual predisposed to diabetes 
on genetic grounds. Prediabetes can be suspected to be present genetically 
in the nondiabetic identical twin of a diabetic patient and in the offspring 
of two conjugal diabetic parents. During the prediabetic period, glucose 
tolerance and cortisone-glucose tolerance tests are normal. A number of find- 
ings indicate that groups of prediabetic subjects can be differentiated from 
groups of normal control subjects although reliable diagnostic tests are not 
available for detection of prediabetes in the individual. A delayed and/or 
decreased plasma insulin response to the stimulus of glucose has been demon- 
strated in groups of genetic prediabetic individuals3-6 and in other nondiabetic 
relatives of diabetic patients 7-Q by a number of investigators. This defect is 
similar to that demonstrated in patients with overt, latent, and subclinical 
diabetes. Vascular changes, reflected by thickening of the capillary basement 
Table 2. Glucose Tolerance Test 
Rapid Progression from “Prediabetes” to Overt Diabetes+ 
-___ 





GTT 82 106 88 85 74 85 79 
Cortisone- 
GTT 81 721 91 84 90 98 67 
350 -- 7 wk of polyuria, polydipsia. 30-lb weight loss, 
fatigue 
KG., male; F.H., father, mother, 2 siblings with diabetes mellitus. 
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membrane of muscle obtained by biopsy, have been found by Siperstein 
et al.rO in 52% of a group of “prediabetic” individuals; cortisone-glucose 
tolerance tests were not performed in these subjects. 
In the natural history of diabetes, progression or regression from one stage 
to the next stage (1) may never occur, or (2) may occur very slowly over 
many years, or (3) may be rapid or even explosive.’ The concept, supported 
by appropriate findings, that there may be fluctuations in the expression of 
the carbohydrate aspects of the disease in either direction is an important 
one. Such fluctuations are particularly common when carbohydrate intoler- 
ance is mild.“~r2 However, even the overt stage of the disease may regress. 
Extreme examples, such as regression from overt ketotic diabetes to pre- 
diabetes, have been reported in individuals who have been in diabetic coma 
and who subsequently exhibited normal standard and normal cortisone- 
glucose tolerance tests. I3 On the other hand, rapid progression from predia- 
betes to overt or symptomatic diabetes without recognition of the inter- 
mediary stage of latent diabetes can be documented as is illustrated by the 
following example (Table 2). KG. was a 16yr-old prediabetic boy, who was 
the offspring of two asymptomatic diabetic parents and the sibhng of two 
ketotic-type diabetics, one of whom had died of diabetic nephropathy. K.G. 
had normal glucose tolerance and normal cortisone-glucose tolerance tests in 
December 19.~4, followed by symptomatic diabetes 10 mo later. 
Table 3 gives an example of very slow progression to overt diabetes. This 
child was seen in our Department of Pediatrics at the age of 6 mo, and was 
referred because of furunculosis and glycosuria. In 1938, this glucose tolerance 
test (Benedict blood glucose method) was called normal and the mother was 
told to forget about any possible abnormality, which she did. The patient 
was readmitted at the age of 14 with a history of upper respiratory infec- 
tion, followed in just a few days by symptoms of overt diabetes. He was in 
diabetic coma and died. It is entirely possible that more effective therapy 
might have saved this child’s life. However, even if a diagnosis of diabetes 
Table 3. Very Slow Progression From Chemical Diabetes to Overt Diabetes* 
1938 - Age 8 mo 
Furunculosis for 6 wk 
Glycosuria (+-+++) for 2 wk 
GTT: F ‘I2 1 2 3 
(mg/lOO ml) 
84 172 153 129 105 
Well until: 
1951 -Age 14 yr 
12/2 Sore throat, anorexia, restlessness 
12/6 Polyuria, polydipsia 
12/7 Air hunger, confusion 
12/8 Coma 
Urine: ++++ glucose and ketone bodies 
COa comb. power: 5 meq/liter 
NPN: 92 mg/lOO ml 
l F.P., male. 
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was not possible in 1938, close followup with periodic testing should have 
been advised. It is possible that this unfortunate death might have been 
prevented by recognition of the disease before complete decompensation of 
islet cell function occurred. 
In Table 4, an example is given of a remission of overt diabetes complicated 
by diabetic coma to the prediabetic stage (on the basis of a normal glucose 
tolerance test). A year later abnormal glucose tolerance indicated latent or 
chemical diabetes. 
A longer remission of overt diabetes is shown in Table 5. A $I-yr-old 
male was in profound diabetic coma. Insulin therapy was discontinued 6 wk 
later and shortly thereafter the glucose tolerance test was normal. Three yr 
later he had a normal glucose tolerance test and a normal cortisone-glucose 
Table 4. Temporary Remission of Overt Diabetes’ 










330 Urine: ++++ Acetone 
Serum CO* content: 8.5 meq/liter 
Serum pH: 7.18 
Insulin therapy discontinued 
75 150 80 
97 186 200 260 
_____~_. ~~__ 
Table 5. Remission of Overt Diabetes* 
10/12/54 
11/27/54 
Profound diabetic coma, circulatory collapse 
B.S.: 1280 mg/lOO ml; Urine: ++++ Acetone 
Plasma CO2 C.P.: 3 meq/liter; BUN: 60 mg/lOO ml 
Insulin therapy discontinued 
Test. F ‘12 1 I’/? 2 2’tz 3 
(mg/lOO ml) 
12117754 GTT: 82 154 100 113 
6/29/57 GTT: 82 104 76 90 131 104 110 
6/30/57 Cortisone-GTT: 84 156 158 127 90 98 82 
*R.W., male, 41 yr. 
By permission.13 
Table 6. Regression of Latent (Chemical) Diabetes to Prediabetes* 
1 ‘I? 
Date Age Wt (kg) Test: F ‘I1 1 (mg/lOO ml) 2 21/z 3 
l/12/54 34 101 GTT: 102 175 260 247 236 128 99 
5/15/43 79 
11/29/54 98 GTT: 89 150 160 132 104 89 66 
11/30/54 Cortisone- 
GTT: 97 173 140 104 97 85 85 
41 5163 43 109 died of myocardial infarction 
l J.P., male; F.H., diabetes in father, mother, one bothers, and two sisters. 
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Table 7. “Maturity-onset-type” Diabetes in Childhood* 
Glucose Tolerance Test Weight 
Date Age F ‘I1 1 1 ‘I1 2 2’12 3 Height (lb) 
(mg/lOO ml) 
l/12/54 10 94 146 214 207 161 160 135 
11/29/54 10 a5 - 129 146 100 118 104 
51 6158 14 a2 105 136 142 150 105 - 
5/19/59 15 92 144 la5 157 156 164 133 
11/23/59 15 
l/16/61 17 
31 6/62 la 
3/ 4/63 19 









27 101 210 269 238 246 227 165 
91 125 132 106 136 120 102 
Delivery: M, 6 lb, 6 oz 
Delivery: F, 11 lb, 6 oz 
88 - 224 - 207 162 - 
Oral Tolbutamide Test: Per cent of FBS: 
20 min-97%, 30 min-65°/0, 40 min-600/0 
Delivery: M, 10 Ibs, 6 oz 
a7 169 - la2 168 
a5 149 207 222 212 161 131 
4 ft 9 in. 118 
(1400-cal diet) 
110 
5 ft 2’12 in. 177 
5 ft 2’/4 in. 178 
(1400-cal diet) 
160 
5 ft 3 in. 205 




*A.P.S., female; F.H., diabetes: (1) Father-died of vascular disease: (2) Mother-died 
of vascular disease; (3) two brothers (one died of vascular disease) and one sister. 
tolerance test (prediabetes). I would like to emphasize again that if one can 
have regression from the most advanced stage to the prediabetic stage, then 
one should not be surprised that, as reported by O’Sullivan and Hurwitz,” 
27% of young women with grossly abnormal glucose tolerance tests reverted 
to normal glucose tolerance. Thus, variability in the results of the glucose 
tolerance test in any one individual may be due to biologic variations in the 
individual tested rather than due to variability (“lack of reproducibility”) 
in the test procedure. Other examples are given in the next two tables. 
Table 6. Glucose Tolerance Tests in 7 of 10 Asymptomatic Children of a Diabetic Father 









322 (4+ glucose and acetone) 




113 236 274 267 259 216 175 
(0) (++++) 
(:Y 146 178 141 140 129 157 
(0) 
(:; 175 210 121 160 156 154 
(0) 
109 la3 219 188 161 170 128 
(0) (0) 
*Clinitest reaction noted below blood glucose values in parentheses. 
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J.P. (Table 6) was an offspring of conjugal diabetic parents. He was dia- 
betic, as can be seen from the glucose tolerance test performed on January 
12, 1954. He was grossly overweight, reduced 22 kg in body weight, but 
regained that weight. In spite of a similar degree of obesity, he exhibited 
normal glucose tolerance and normal cortisone-glucose tolerance tests. This 
demonstrates reversion of latent (chemical) diabetes to the prediabetic stage. 
He died of a myocardial infarction 9 yr later at the age of 43. 
Data on this patient’s sister are given in Table 7. A diagnosis of diabetes 
was made at the age of 10 yr. She was overweight. Normal glucose tolerance 
was recorded 10 mo later after modest weight reduction. Borderline glucose 
tolerance was noted at age 14, and definitely abnormal glucose tolerance at 
the age of 15. She gave birth to an infant weighing 11 lb 8 oz. Abnormal 
glucose tolerance was found between the ages of 19 and 27 yr. There has 
been only a minor degree of progression in her carbohydrate intolerance. 
Routine glucose tolerance tests were performed in 10 offspring of a diabetic 
father (Table 8). Seven were found to be diabetic on the first glucose toler- 
ance test. I am showing results obtained in this family to indicate that within 
one family with the same genetic endowment we have a broad range of 
abnormality in carbohydrate tolerance. With an age span of 20 yr among 
these siblings, one gets the impression that progression of latent or chemical 
diabetes need not be rapid even among young nonobese individuals. 
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